NCT00383734View on ClinicalTrials.gov

Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2010

Conditions
HIV-Associated Lipodystrophy Syndrome
Interventions
DEVICE

Newfill

1 to 7 injections of drug

DEVICE

Eutrophill

1 to 7 injections of drug

Trial Locations (1)

75010

Hôpital Saint-Louis Service des Maladies Infectieuses, Paris

Sponsors

Collaborators (2)

Procitech
Sanofi
All Listed Sponsors
collaborator

Procitech

UNKNOWN

collaborator

Sanofi

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV